Planet 13 Holdings Inc.

OTCQX:PLNH USA Drug Manufacturers - Specialty & Generic
Market Cap
$65.07 Million
Market Cap Rank
#21630 Global
#7733 in USA
Share Price
$0.20
Change (1 day)
-13.04%
52-Week Range
$0.20 - $0.32
All Time High
$0.93
About

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. It owns, manufactures, and sells cannabis products in the form of gummies and beverages, chocolates, vapes and concentrates, and flowers under the TRENDI, Leaf and Vine, Dreamland, HaHa, and Medizin brand names. The c… Read more

Planet 13 Holdings Inc. (PLNH) - Net Assets

Latest net assets as of September 2025: $54.58 Million USD

Based on the latest financial reports, Planet 13 Holdings Inc. (PLNH) has net assets worth $54.58 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($158.50 Million) and total liabilities ($103.91 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $54.58 Million
% of Total Assets 34.44%
Annual Growth Rate 22.23%
5-Year Change -6.62%
10-Year Change N/A
Growth Volatility 80.43

Planet 13 Holdings Inc. - Net Assets Trend (2019–2024)

This chart illustrates how Planet 13 Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Planet 13 Holdings Inc. (2019–2024)

The table below shows the annual net assets of Planet 13 Holdings Inc. from 2019 to 2024.

Year Net Assets Change
2024-12-31 $112.71 Million +4.71%
2023-12-31 $107.64 Million -43.61%
2022-12-31 $190.89 Million +9.89%
2021-12-31 $173.71 Million +43.91%
2020-12-31 $120.70 Million +192.30%
2019-12-31 $41.29 Million --

Equity Component Analysis

This analysis shows how different components contribute to Planet 13 Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 23554285300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components $368.82 Million 327.22%
Total Equity $112.71 Million 100.00%

Planet 13 Holdings Inc. Competitors by Market Cap

The table below lists competitors of Planet 13 Holdings Inc. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Planet 13 Holdings Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 107,640,781 to 112,713,921, a change of 5,073,140 (4.7%).
  • Net loss of 47,796,856 reduced equity.
  • Other factors increased equity by 52,869,996.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-47.80 Million -42.41%
Other Changes $52.87 Million +46.91%
Total Change $- 4.71%

Book Value vs Market Value Analysis

This analysis compares Planet 13 Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.58x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 $0.30 $0.20 x
2020-12-31 $0.66 $0.20 x
2021-12-31 $0.87 $0.20 x
2022-12-31 $0.87 $0.20 x
2023-12-31 $0.48 $0.20 x
2024-12-31 $0.35 $0.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Planet 13 Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -42.41%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -41.06%
  • • Asset Turnover: 0.56x
  • • Equity Multiplier: 1.83x
  • Recent ROE (-42.41%) is below the historical average (-28.39%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 -16.12% -10.47% 1.01x 1.52x $-10.79 Million
2020 -6.58% -11.27% 0.47x 1.24x $-20.01 Million
2021 -11.20% -16.29% 0.55x 1.25x $-36.83 Million
2022 -25.66% -46.84% 0.45x 1.22x $-68.07 Million
2023 -68.38% -74.73% 0.65x 1.41x $-84.37 Million
2024 -42.41% -41.06% 0.56x 1.83x $-59.07 Million

Industry Comparison

This section compares Planet 13 Holdings Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Planet 13 Holdings Inc. (PLNH) $54.58 Million -16.12% 1.90x $46.17 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million